The Supply of Leronlimab will naturally be limited
Post# of 148160
Possibly the FDA will issue a kind of limited EUA, approving the use of Leronlimab for now, to be restricted to certain patients per specific criteria for example co-morbidity categories and s/c symptoms, for patients who are most likely to be saved from death. Just until manufacturing can catch up with demand.